Key result
Emerging lipid biomarkers require further research to clarify their atherogenic potential in children.
Why the study?
The atherogenic potential of many lipid biomarkers remains unclear with no clinical recommendations in place, and the involvement of lipids in atherogenesis in children has yet to be elucidated.
What is the role of traditional and emerging lipid biomarkers in assessing cardiovascular risk and atherosclerosis in the pediatric population?
What is the role of traditional and emerging lipid biomarkers in assessing cardiovascular risk and atherosclerosis in the pediatric population?
Answers are grounded in this paper and cite their sources.
This review highlights the lack of clinical recommendations and the need for further research on emerging lipid biomarkers for cardiovascular risk assessment in children.
Lipids are a complex group of molecules in the body, essential as structural, functional and metabolic components. When disbalanced, they are regarded as a cardiovascular risk factor, traditionally in cholesterol level evaluation. However, due to their complex nature, much research is still needed for a comprehensive understanding of their role in atherosclerosis, especially in the young. Several new lipid biomarkers are emerging, some already researched to a point, such as lipoproteins and apolipoproteins. Other lipid molecules are also being increasingly researched, including oxidized forms due to oxidative inflammation in atherosclerosis, and sphingolipids. For many, even those less new, the atherogenic potential is not clear and no clinical recommendations are in place to aid the clinician in using them in everyday clinical practice. Moreover, lipids' involvement in atherogenesis in children has yet to be elucidated. This review summarizes the current knowledge on lipids as biomarkers of cardiovascular risk in the paediatric population.
No takes yet. Share an insight, caveat, or question.
Močnik et al. (2023) conducted a review in Cardiovascular risk and atherosclerosis. Lipid biomarkers was evaluated. Emerging lipid biomarkers, including oxidized forms and sphingolipids, require further research to elucidate their atherogenic potential and role in cardiovascular risk assessment in children.
Synapse has enriched 10 related papers. Consider them for comparative context: